---
title: "Triflupromazine - Psychotic disorder - 5"
sidebar: mydoc_sidebar
permalink: db00508-mesh-d011618-5.html
toc: false 
---


Path ID: `DB00508_MESH_D011618_5`
{% include image.html url="images/db00508-mesh-d011618-5.png" file="db00508-mesh-d011618-5.png" alt="db00508-mesh-d011618-5" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D014273 | triflupromazine | Drug |
| UniProt:P41595 | 5-hydroxytryptamine receptor 2B | Protein |
| UBERON:0001017 | central nervous system | GrossAnatomicalStructure |
| HP:0008760 | violent behavior | PhenotypicFeature |
| MESH:D011618 | psychotic disorders | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Triflupromazine | DECREASES ACTIVITY OF | 5-Hydroxytryptamine Receptor 2B |
| 5-Hydroxytryptamine Receptor 2B | LOCATED IN | Central Nervous System |
| Central Nervous System | PREVENTS | Violent Behavior |
| Violent Behavior | CORRELATED WITH | Psychotic Disorders |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB00508#mechanism-of-action](https://go.drugbank.com/drugs/DB00508#mechanism-of-action){:target="_blank"}